Whoah EBV not only causes multiple sclerosis, it also might be the root of SLE www.science.org/doi/10.1126/... An EBV vaccine to rid ourselves of these horrible autoimmune conditions (and many cancers)? #lupus #medsky #RheumSky @christosargyrop.bsky.social

16 is same as last year someone check if I have missed anything Read our blogs here www.nephjc.com/news/kidneyw... #NephJC #KidneyWk @nephroseeker.medsky.social @brendonneuen.bsky.social

Cui for a study of membranous with MIL62 #KidneyWk

Late breakers that included children: ✅Setanaxib in Alport (12+) Late breakers that did NOT include children: 🚫Atacicept in IgAN 🚫CONFIDENCE 🚫PISCES: Fish oil in Dialysis 🚫LIBERATE-D 🚫balcinrenone + dapa 🚫Obintuzumab in lupus nephritis 🚫Sibeprenlimab in IgA 🚫MIL62 in membranous +more #KidneyWk

And another ns-MRA Balcinrenone added to Dapa in proteinuric CKD #KidneyWK @thelancet.com www.thelancet.com/journals/lan...

The second sibeprenlimab paper in @nejm.org (At least we gave it an oral at #KidneyWk unlike the poster for the phase 2 data in 2023!) www.nejm.org/doi/full/10....

Cure for #KidneyWk FOMO #NephJC summary of all simultaneous publications-Day 2

And the GBD analysis on CKD From @paddymark.bsky.social and colleagues www.thelancet.com/journals/lan... in @thelancet.com #KidneyWk

And paper 3 from @cervantes-lily1.bsky.social On adaptation of the Navigate Kidney intervention in @kireports.bsky.social www.kireports.org/article/S246... #KidneyWk

Check out this new editorial in #ASNJASN and simultaneously published for #KidneyWk: "Redefining Immunosuppression in Older Kidney Transplant Recipients: Reflections on the OPTIMIZE Study." Read more: kidney.pub/JASN0939

Simultaneous publication #kidneyWk #Nephsky #NephJC

Don't forget! Tonight is #NephJC night, and it will be a blast 🪩 👋If you're on #KidneyWk, don't be shy, just say hi ✨For tickets, location, and more specifics, see the link 👇👇 www.nephjc.com/news/2025/10...

Now live in #ASNJASN, simultaneously published with #KidneyWk: "Immunosuppression in Older Kidney Transplant Recipients: A Randomized Controlled Trial" Read more: kidney.pub/JASN0924

Rethinking my #KidneyWk FOMO.... If day 1 looked promising, day 2 already has 4 sim pub (see tomorrow's #NephJC newsletter). ✍️🔥Lots of reading and writing to do #Nephsky #Medsky

In PISCES, daily n–3 fatty acids cut serious cardiovascular events in dialysis patients by nearly half (HR 0.57). Fish oil clearly had bigger fish to fry than placebo: fewer MIs, strokes, cardiac deaths without extra adverse catches @nejm.org #kidneywk sim publication www.nejm.org/doi/full/10....

In the afternoon another late breaking oral session among other things at 4:30 pm @brendonneuen.bsky.social Lorundrostat A new oral GLP1 REMODEL to understand sema mechanism GBD kidney disease with @paddymark.bsky.social And @cervantes-lily1.bsky.social ! #KidneyWk

Today’s trials at #KidneyWk In the morning a LBCT session at 10:30 featuring PISCES (fish oil in dialysis!) LIBERATE in AKI Another AKI alerts from @fperrywilson.bsky.social A Transplant trial GLP1 and a Flozin analyses And

Highlights from my talk yesterday on Alport syndrome spectrum of disorders. (since no one posted it, I'll have to do it myself) Variants in type IV collagen cause a wide spectrum of disease. #KidneyWk 🧵

Couldn't attend #KidneyWk in person, but ASN uploaded the 1st day plenary session on YouTube 👇 ✅Check it out: the president's address, the state-of-the-art lecture by Vlado Perkovic 🎲 High-impact clinical trials: ORIGIN-3 & FINE-ONE www.youtube.com/watch?v=FMxW...

We have a new therapy for type 1 diabetes! FINE-ONE with significant proteinuria reduction compared to placebo on a background of RASi with an acceptable safety profile. Where’s the simultaneous pub?? Sglt2 inhibitors are next…#kidneywk

Application for #NephSIM Nephrons are due 11/13: A 6-mo virtual program for US medical students/residents interested in learning more about #nephrology & neph careers Learn more at the #KidneyWk @kidney.org @nkf-professionals.bsky.social booth in the Exhibition Hall 🫘 nephsim.com/nephsim-neph...

Live from #KidneyWk: ORiGIN trial 👉prespecified interim analysis 📉treatment with atacicept resulted in a significantly greater reduction in proteinuria than placebo at week 36 in patients with IgAN Simultaneous @nejm.org publication 👇👇 www.nejm.org/doi/full/10....

While having FOMO for not being at #KidneyWk , looking at the #NephMadness logo for 2026. Can’t wait for it 🤩

After a 40 minute handa on session where my station worked on kidney US we are back in the lecture room for a talk on lung ultrasound by Nathaniel Reisinger #KidneyWk

#NephJC at #KidneyWk 🔥🔥We have all sorts of events 🗓️ Friday, a classic: #NephJC night- #NephJCKidney Awards, @freelyfiltered.bsky.social live recording + lots of fun 🗓️ Saturday, Nov 8th, 6:30 am- will start the day with a nephro run 🏃🏃 For more info 👇👇 www.nephjc.com

It's that time of year again 🍂🍂🍂 The #NephJC Fall pledge drive. Plese give if you are able to support our decades long mission of #FOAMed for all. #NephSky #MedSky www.nephjc.com/news/2025/9/22/nephjc-fall-pledge-drive

We uncovered a powerful type I interferon signature in #ANCA #vasculitis, especially in MPA, tied to kidney prognosis, and close to lupus nephritis. 🚀 This opens exciting perspectives for IFN–targeted therapies in vasculitis. Full results presented at #KidneyWk @asnkidney.bsky.social in a few hours!

Moving beyond N of 1 case reports! The first clinical trial of 🐷 kidneys begins N = 6, poss or expansion to 50 United Therapeutics (NYU, UAB have used this model) ca.finance.yahoo.com/news/first-c...

💗 Loved this episode. The puns were great, the trial story is even better! What really stood out was the resilience behind it. ✨Five tries to ACHIEVE the first grant, then 11 in total

Renal tubular epithelial cell cast (Sternheimer-Malbin stain) under 1000x bright field. Pt with nephrotic range proteinuria, suspected GN. Note small lipid droplets on most inferior cell in the cast.

eGFR slope before a clinical trial may assist in selecting participants at risk of kidney outcomes in whom new therapies are needed. Read more from this #ASNCJASN original research here: kidney.pub/CJASN0810#ASNCJASN

Listen to the latest episode of the Burton Rose Book Club @juancarlosqvelez.bsky.social #cigarshaped CaOx crystals for ethylene glycol toxicity (not classic envelope shaped) #pearlsbyJCV www.nejm.org/doi/full/10....

The BICAR-ICU-2 trial just dropped! RCT involving IV bicarb in metabolic acidosis among patients with mod-severe AKI Bicarb didn't affect mortality but it reduced the need for dialysis & risk of bacteremia VERY similar conclusions to BICAR-ICU-1 🧵 #1/ jamanetwork.com/journals/jam... #EMIMCC

As nephrologists, we tend to focus on pathways, labs, and outcome curves. For years, IgAN meant familiar drugs and modest gains. Reading new guidelines through a patient’s story is a reminder of why it matters #nephjc Perspective by @jonathanpollack.bsky.social www.nephjc.com/news/2025/10...

The 2025 @kdigo.org IgAN guideline quietly redraws the map: new drugs, new thresholds, and a sense that the era of “supportive care only” is finally over #Nephsky #Medsky ✍️Summary by @thekidneywhisperer.bsky.social and @glomerican.bsky.social www.nephjc.com/news/igan-kd...

El próximo #NephJC se centra en la guía de nefropatía por IgA. 🎨 Buen resumen visual de @roxnonna23.bsky.social 🌐 Traducido por @dramiliflores.bsky.social www.nephjc.com/news/2025/10...

⏩ Next #NephJC is on IgA nephropathy @kdigo.org guideline 🎨 Nice visual summary by @roxnonna23.bsky.social www.nephjc.com/news/2025/10...

What is the impact of dietary micronutrient intake on the metabolome in children with CKD? This #ASNCJASN original research digs deep: kidney.pub/CJASN0811#ASNCJASN

1/10 Last #NephJC we tried to answer the question whether protein supplementation increases health related QoL 🥩💊#TenPostNephJC . Read the article 👇 pubmed.ncbi.nlm.nih....#NephJC

The latest empadata dump: @nephroseeker.medsky.social writes up a #NephJC short on the meta analysis www.nephjc.com/news/2025/10...

Obinituzumab aka ‘Obi’ is now FDA approved for lupus nephritis finance.yahoo.com/news/fda-app... #lupus

📅 Coming next week, October 23, 2025, at 5:00 PM (CEST) #Nephsky #Medsky ✨E-seminar: Interventional Nephrology- A Beginner’s Guide for Young Nephrologists 🎙️Presenting @drbarbateba.bsky.social 💬Moderator @hugodiniz.medsky.social 👉You can register here www.era-online.org/video-pages/...

🥲 Looking at published abstract for #KidneyWk this year, I realize I'll have a bigger FOMO than anticipated LBCTs - all sorts of them: posters: special sessions, right during plenary sessions @asnkidney.bsky.social why are u the only big nephro organization that doesn't have hybrid options?

Don’t forget to support #FOAMed and #NephJC with our annual fundraiser. Every donation helps keep us going (even as unpaid volunteers). www.nephjc.com#FOAMed

Up next! ☀️📚 We're going back to the guidelines with KDIGO IgA, which is already out of date (isn’t that awesome) #NephJC pubmed.ncbi.nlm.nih....#NephJC

Funnier (and excellently written) blog for the Indian setting here lastmonthinnephrology.wordpress.com/2024/03/25/p... #NephJC

Here’s @kidneyboy.bsky.social take on that study pbfluids.com/2009/02/jour... #NephJC

Pre #nephjc bias: Team pro protein All these studies are deeply confounded and based in the pre-kidney-preserving therapy era. Let them eat steak! (Actually, let them eat vegetable sources of protein, but beans, lentils, and soy don’t rhyme with cake)

🎨Beautiful visual abstract by @msocomd.bsky.social #NephJC